he added: �these findings show that despite the tireless work of doctors and nurses, it appears that some cancer patients are still enduring shockingly long waits to start treatment..

"their serious adverse incident process has been wholly inadequate and what we have heard this week is a damning indictment of the western trust...

cambridge's bluebird bio licenses delivery tech to novartis, gsk.

04:49